-
Name:Boceprevir
Catalog No.:B0005
Structure:
Chemical Properties Cas No.:394730-60-0 Purity Limit: Synonyms: Molecular Weight:519.34 Formula:C27H45N5O5 Storage: Solubility:
Shipping Condition
Quality Control & MSDS
Description Boceprevir (INN, trade name Victrelis) is a protease inhibitor used as a treatment for hepatitis C genotype 1. It binds to HCV nonstructural 3 NS3 (HCV) active site. It was being developed by Schering-Plough, but is now being developed by Merck since Schering was acquired in 2009. It was approved by the FDA on May 13, 2011
References Related products
- Atazanavir
- Tenofovir alafenamide
- Telaprevir
- Ixazomib
- Odanacatib
- L685458
- Emricasan
- Belnacasan
- Cobicistat
- Ispinesib
Tel: +86-411-39042497
sales@alphabiopham.com
Contact us now!
We'll offer you the best prices